Integrated Filing — IndAS
General information about company
| Scrip Code |
508869 |
| NSE Symbol |
APOLLOHOSP |
| MSEI Symbol |
NOTLISTED |
| ISIN |
INE437A01024 |
| Name of company |
APOLLO HOSPITALS ENTERPRISE LIMITED |
| Type of company |
Main Board |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2026 |
| Date of end of financial year |
31-03-2027 |
| Date of board meeting when results were approved |
04-11-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed
to the exchange |
|
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
Second quarter |
| Nature of report standalone or consolidated |
Consolidated |
| Whether results are audited or unaudited for the quarter ended |
Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
Unaudited |
| Segment Reporting |
Multi segment |
| Description of single segment |
|
| Start date and time of board meeting |
04-11-2026 03:20:00 |
| End date and time of board meeting |
04-11-2026 05:35:00 |
| Whether cash flow statement is applicable on company |
Yes |
| Type of cash flow statement |
Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
Financial Results Ind-AS
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-07-2026 |
01-04-2026 |
| B |
Date of end of reporting period |
30-09-2026 |
30-09-2026 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
| 1 |
Income |
|
Revenue from operations |
7,61,490.00 |
14,54,680.00 |
|
Other income |
4,480.00 |
9,270.00 |
|
Total income |
7,65,970.00 |
14,63,950.00 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
93,520.00 |
1,75,020.00 |
| (b) |
Purchases of stock-in-trade |
3,05,900.00 |
5,82,680.00 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
(4,260.00) |
(4,230.00) |
| (d) |
Employee benefit expense |
87,320.00 |
1,65,020.00 |
| (e) |
Finance costs |
11,400.00 |
22,210.00 |
| (f) |
Depreciation, depletion and amortisation expense
|
23,020.00 |
45,260.00 |
| (f) |
Other Expenses |
| 1 |
Other Expenses |
1,59,930.00 |
3,09,410.00 |
|
Total other expenses |
1,59,930.00 |
3,09,410.00 |
|
Total expenses |
6,76,830.00 |
12,95,370.00 |
| 3 |
Total profit before exceptional items and tax |
89,140.00 |
1,68,580.00 |
| 4 |
Exceptional items |
0.00 |
0.00 |
| 5 |
Total profit before tax |
89,140.00 |
1,68,580.00 |
| 6 |
Tax expense |
|
| 7 |
Current tax |
25,420.00 |
46,450.00 |
| 8 |
Deferred tax |
(930.00) |
(3,120.00) |
| 9 |
Total tax expenses |
24,490.00 |
43,330.00 |
| 10 |
Net movement in regulatory deferral account balances related to profit or loss and
the related deferred tax movement |
0.00 |
0.00 |
| 11 |
Net Profit Loss for the period from
continuing operations |
64,650.00 |
1,25,250.00 |
| 12 |
Profit (loss) from discontinued operations before tax |
490.00 |
(410.00) |
| 13 |
Tax expense of discontinued operations |
380.00 |
380.00 |
| 14 |
Net profit (loss) from discontinued
operation after tax |
110.00 |
(790.00) |
| 15 |
Share of profit (loss) of associates and joint ventures accounted for using equity
method |
1,190.00 |
2,530.00 |
| 16 |
Total profit (loss) for period |
65,950.00 |
1,26,990.00 |
| 17 |
Other comprehensive income net of taxes |
(860.00) |
(470.00) |
| 18 |
Total Comprehensive Income for the period |
65,090.00 |
1,26,520.00 |
| 19 |
Total profit or loss, attributable to
|
|
|
|
Profit or loss, attributable to owners of parent |
62,990.00 |
1,21,060.00 |
|
Total profit or loss, attributable to non-controlling interests |
2,960.00 |
5,930.00 |
| 20 |
Total Comprehensive income for the period attributable to |
|
|
|
Comprehensive income for the period attributable to owners of parent |
62,120.00 |
1,20,590.00 |
|
Total comprehensive income for the period attributable to owners of parent non-controlling
interests |
2,970.00 |
5,930.00 |
| 21 |
Details of equity share capital |
|
|
Paid-up equity share capital |
7,190.00 |
7,190.00 |
|
Face value of equity share capital |
5 |
5 |
| 27 |
Details of debt securities |
|
| 22 |
Reserves excluding revaluation reserve |
|
|
| 23 |
Earnings per share |
|
| i |
Earnings per equity share for continuing operations |
|
|
Basic earnings (loss) per share from continuing operations |
43.74 |
84.74 |
|
Diluted earnings (loss) per share from continuing operations |
43.71 |
84.69 |
| ii |
Earnings per equity share for discontinued operations |
|
|
Basic earnings (loss) per share from discontinued operations |
0.08 |
-0.55 |
|
Diluted earnings (loss) per share from discontinued operations |
0.08 |
-0.55 |
| ii |
Earnings per equity share |
|
|
Basic earnings (loss) per share from continuing
and discontinued operations |
43.82 |
84.19 |
|
Diluted earnings (loss) per share from
continuing and discontinued operations |
43.79 |
84.14 |
| 24 |
Debt equity ratio |
|
|
| 25 |
Debt service coverage ratio |
|
|
| 26 |
Interest service coverage ratio |
|
|
| 27 |
Disclosure of notes on financial results |
|
Remarks
Statement of Asset and Liabilities
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-04-2026 |
| Date of end of reporting period |
30-09-2026 |
| Whether results are audited or unaudited |
Unaudited |
| Nature of report standalone or consolidated |
Consolidated |
|
Assets |
| 1 |
Non-current assets |
|
Property, plant and equipment |
11,00,320.00 |
|
Capital work-in-progress |
1,49,390.00 |
|
Investment property |
190.00 |
|
Goodwill |
1,03,000.00 |
|
Other intangible assets |
16,750.00 |
|
Intangible assets under development |
4,330.00 |
|
Biological assets other than bearer plants |
0.00 |
|
Investments accounted for using equity method |
27,390.00 |
|
Non-current financial assets |
|
|
Non-current investments |
90,750.00 |
|
Trade receivables, non-current |
0.00 |
|
Loans, non-current |
230.00 |
|
Other non-current financial assets |
|
| 1 |
Other non-current financial assets |
25,440.00 |
|
Total of other non-current financial assets |
25,440.00 |
|
Total non-current financial assets |
1,16,420.00 |
|
Deferred tax assets (net) |
1,380.00 |
|
Other non-current assets |
|
| 1 |
Other non-current assets |
31,820.00 |
|
Total of other non-current assets |
31,820.00 |
|
Total non-current assets |
15,50,990.00 |
| 2 |
Current assets |
|
|
Inventories |
62,340.00 |
|
Current financial asset |
|
|
Current investments |
1,01,030.00 |
|
Trade receivables, current |
4,25,620.00 |
|
Cash and cash equivalents |
58,740.00 |
|
Bank balance other than cash and cash equivalents |
78,340.00 |
|
Loans, current |
1,060.00 |
|
Other current financial assets |
|
|
Total of other current financial assets |
38,430.00 |
|
Total current financial assets |
7,03,220.00 |
|
Current tax assets (net) |
14,420.00 |
|
Other current assets |
|
| 1 |
Other current assets |
38,190.00 |
|
Total of other current assets |
38,190.00 |
|
Total current assets |
8,18,170.00 |
| 3 |
Non-current assets classified as held for sale |
53,060.00 |
| 4 |
Regulatory deferral account debit balances and related deferred tax Assets |
0.00 |
|
Total assets |
24,22,220.00 |
|
Equity and liabilities |
|
| 1 |
Equity |
|
|
Equity attributable to owners of parent |
|
|
Equity share capital |
7,190.00 |
|
Other equity |
10,53,230.00 |
|
Total equity attributable to owners of parent |
10,60,420.00 |
|
Non controlling interest |
55,290.00 |
|
Total equity |
11,15,710.00 |
| 2 |
Liabilities |
|
|
Non-current liabilities |
|
|
Non-current financial liabilities |
|
|
Borrowings, non-current |
2,44,870.00 |
|
Trade payables, non-current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
0.00 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
0.00 |
|
Total Trade payable |
0.00 |
|
Other non-current financial liabilities |
|
| 1 |
Lease liabilities |
2,39,940.00 |
| 2 |
Other financial liabilities |
3,410.00 |
|
Total of other non-current financial liabilities |
2,43,350.00 |
|
Total non-current financial liabilities |
4,88,220.00 |
|
Provisions, non-current |
7,600.00 |
|
Deferred tax liabilities (net) |
46,850.00 |
|
Deferred government grants, Non-current |
0.00 |
|
Other non-current liabilities |
|
| 1 |
Other non-current liabilities |
1,330.00 |
|
Total of other non-current liabilities |
1,330.00 |
|
Total non-current liabilities |
5,44,000.00 |
|
Current liabilities |
|
|
Current financial liabilities |
|
|
Borrowings, current |
3,14,610.00 |
|
Trade payables, current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
10,800.00 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
2,64,970.00 |
|
Total Trade payable |
2,75,770.00 |
|
Other current financial liabilities |
|
| 1 |
Lease liabilities |
15,510.00 |
| 2 |
Other financial liabilities |
38,000.00 |
|
Total of other current financial liabilities |
53,510.00 |
|
Total current financial liabilities |
6,43,890.00 |
|
Other current liabilities |
30,680.00 |
| 1 |
Other current liabilities |
30,680.00 |
|
Total of other current liabilities |
30,680.00 |
|
Provisions, current |
17,360.00 |
|
Current tax liabilities (Net) |
90.00 |
|
Deferred government grants, Current |
0.00 |
|
Total current liabilities |
6,92,020.00 |
| 3 |
Liabilities directly associated with assets in disposal group classified as held for sale |
70,490.00 |
| 4 |
Regulatory deferral account credit balances and related deferred tax liability |
0.00 |
|
Total liabilities |
13,06,510.00 |
|
Total equity and liabilites |
24,22,220.00 |
|
Disclosure of notes on assets and liabilities |
|
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-07-2026 |
01-04-2026 |
| Date of end of reporting
period |
30-09-2026 |
30-09-2026 |
| Whether results are audited
or unaudited |
Unaudited |
Unaudited |
| Nature of report standalone or
consolidated |
Consolidated |
Consolidated |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
| 1 |
a) Healthcare services |
3,96,300.00 |
7,57,310.00 |
| 2 |
b) Retail health and diagnostics |
42,930.00 |
81,720.00 |
| 3 |
c) Retail health and diagnostics-Discontinued operations |
0.00 |
0.00 |
| 4 |
c) Digital health and pharmacy distribution |
3,28,580.00 |
6,26,280.00 |
| 5 |
d) Others |
0.0064 |
1,710.00 |
|
Total Segment Revenue |
7,68,450.00 |
14,67,020.00 |
|
Less: Inter segment revenue |
6,960.00 |
12,340.00 |
|
Revenue from operations |
7,61,490.00 |
14,54,680.00 |
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
| 1 |
a) Healthcare services |
76,000.00 |
1,44,440.00 |
| 2 |
b) Retail health and diagnostics |
3,800.00 |
5,910.00 |
| 3 |
c) Retail health and diagnostics-Discontinued operations |
110.00 |
(790.00) |
| 4 |
c) Digital health and pharmacy distribution |
17,280.00 |
32,510.00 |
| 5 |
d) Others |
(1,020.00) |
(1,340.00) |
|
Total Profit before tax |
96,170.00 |
1,80,730.00 |
|
i. Finance cost |
11,400.00 |
22,210.00 |
|
ii. Other Unallocable Expenditure net off Unallocable income |
(5,670.00) |
(11,800.00) |
|
Profit before tax |
90,440.00 |
1,70,320.00 |
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
| 1 |
a) Healthcare services |
17,75,440.00 |
17,75,440.00 |
| 2 |
b) Retail health and diagnostics |
1,15,790.00 |
1,15,790.00 |
| 3 |
c) Retail health and diagnostics-Discontinued operations |
53,060.00 |
53,060.00 |
| 4 |
c) Digital health and pharmacy distribution |
4,62,410.00 |
4,62,410.00 |
| 5 |
d) Others |
15,520.00 |
15,520.00 |
|
Total Segment Asset |
24,22,220.00 |
24,22,220.00 |
|
Un-allocable Assets |
0.00 |
0.00 |
|
Net Segment Asset |
24,22,220.00 |
24,22,220.00 |
| 4 |
Segment Liabilities |
|
Segment Liabilities |
| 1 |
a) Healthcare services |
6,26,970.00 |
6,26,970.00 |
| 2 |
b) Retail health and diagnostics |
1,49,480.00 |
1,49,480.00 |
| 3 |
c) Retail health and diagnostics-Discontinued operations |
70,490.00 |
70,490.00 |
| 4 |
c) Digital health and pharmacy distribution |
4,40,350.00 |
4,40,350.00 |
| 5 |
d) Others |
19,210.00 |
19,210.00 |
|
Total Segment Liabilities |
13,06,500.00 |
13,06,500.00 |
|
Un-allocable Liabilities |
0.00 |
0.00 |
|
Net Segment Liabilities |
13,06,500.00 |
13,06,500.00 |
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-07-2026 |
01-04-2026 |
| B |
Date of end of reporting period |
30-09-2026 |
30-09-2026 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
| 1 |
Remeasurement gains / (losses) on defined benefit plan |
(1,090.00) |
(690.00) |
|
Total Amount of items that will not be reclassified to profit and loss |
(1,090.00) |
(690.00) |
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
(190.00) |
(170.00) |
| 3 |
Amount of items that will be reclassified to profit and loss |
|
| 1 |
Exchange differences in translating the financial statements of foreign operations |
40.00 |
50.00 |
|
Total Amount of items that will be reclassified to profit and loss |
40.00 |
50.00 |
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
0.00 |
0.00 |
| 5 |
Total Other comprehensive income |
(860.00) |
(470.00) |
Cash flow statement, indirect
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-04-2026 |
| B |
Date of end of reporting period |
30-09-2026 |
| C |
Whether results are audited or unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
|
Statement of cash flows |
|
|
Cash flows from used in operating
activities |
|
|
Profit before tax |
1,68,580.00 |
|
Adjustments for reconcile profit (loss) |
|
|
Adjustments for finance costs |
22,210.00 |
|
Adjustments for decrease (increase) in inventories |
(8,490.00) |
|
Adjustments for decrease (increase) in trade receivables, current |
(85,710.00) |
|
Adjustments for decrease (increase) in trade receivables, non-current
|
0.00 |
|
Adjustments for decrease (increase) in other current assets |
(8,910.00) |
|
Adjustments for decrease (increase) in other non-current assets |
0.00 |
|
Adjustments for other financial assets, non-current |
(8,120.00) |
|
Adjustments for other financial assets, current |
0.00 |
|
Adjustments for other bank balances |
0.00 |
|
Adjustments for increase (decrease) in trade payables, current |
60,110.00 |
|
Adjustments for increase (decrease) in trade payables, non-current |
0.00 |
|
Adjustments for increase (decrease) in other current liabilities |
820.00 |
|
Adjustments for increase (decrease) in other non-current liabilities
|
0.00 |
|
Adjustments for depreciation and amortisation expense |
45,260.00 |
|
Adjustments for impairment loss reversal of impairment loss recognised
in profit or loss |
5,760.00 |
|
Adjustments for provisions, current |
(3,720.00) |
|
Adjustments for provisions, non-current |
0.00 |
|
Adjustments for other financial liabilities, current |
8,090.00 |
|
Adjustments for other financial liabilities, non-current |
0.00 |
|
Adjustments for unrealised foreign exchange losses gains |
0.00 |
|
Adjustments for dividend income |
20.00 |
|
Adjustments for interest income |
3,130.00 |
|
Adjustments for share-based payments |
6,160.00 |
|
Adjustments for fair value losses (gains) |
(2,960.00) |
|
Adjustments for undistributed profits of associates |
0.00 |
|
Other adjustments for which cash effects are investing or financing
cash flow |
(420.00) |
|
Other adjustments to reconcile profit (loss) |
0.00 |
|
Other adjustments for non-cash items |
(2,920.00) |
|
Share of profit and loss from partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Total adjustments for reconcile
profit (loss) |
24,010.00 |
|
Net cash flows from (used in)
operations |
1,92,590.00 |
|
Dividends received |
0.00 |
|
Interest paid |
0.00 |
|
Interest received |
0.00 |
|
Income taxes paid (refund) |
43,260.00 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
operating activities |
1,49,330.00 |
|
Cash flows from used in
investing activities |
|
|
Cash flows from losing control of subsidiaries or other businesses |
0.00 |
|
Cash flows used in obtaining control of subsidiaries or other businesses |
30.00 |
|
Other cash receipts from sales of equity or debt instruments of other
entities |
96,490.00 |
|
Other cash payments to acquire equity or debt instruments of other entities
|
92,230.00 |
|
Other cash receipts from sales of interests in joint ventures |
0.00 |
|
Other cash payments to acquire interests in joint ventures |
0.00 |
|
Cash receipts from share of profits of partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Cash payment for investment in partnership firm or association of persons or
limited liability partnerships |
0.00 |
|
Proceeds from sales of property, plant and equipment |
430.00 |
|
Purchase of property, plant and equipment |
1,19,990.00 |
|
Proceeds from sales of investment property |
0.00 |
|
Purchase of investment property |
0.00 |
|
Proceeds from sales of intangible assets |
0.00 |
|
Purchase of intangible assets |
0.00 |
|
Proceeds from sales of intangible assets under development |
0.00 |
|
Purchase of intangible assets under development |
0.00 |
|
Proceeds from sales of goodwill |
0.00 |
|
Purchase of goodwill |
0.00 |
|
Proceeds from biological assets other than bearer plants |
0.00 |
|
Purchase of biological assets other than bearer plants |
0.00 |
|
Proceeds from government grants |
0.00 |
|
Proceeds from sales of other long-term assets |
0.00 |
|
Purchase of other long-term assets |
0.00 |
|
Cash advances and loans made to other parties |
0.00 |
|
Cash receipts from repayment of advances and loans made to other parties |
510.00 |
|
Cash payments for future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Cash receipts from future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Dividends received |
830.00 |
|
Interest received |
2,750.00 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
(30,140.00) |
|
Net cash flows from (used in)
investing activities |
(1,41,380.00) |
|
Cash flows from used in
financing activities |
|
|
Proceeds from changes in ownership interests in subsidiaries |
0.00 |
|
Payments from changes in ownership interests in subsidiaries |
0.00 |
|
Proceeds from issuing shares |
630.00 |
|
Proceeds from issuing other equity instruments |
0.00 |
|
Payments to acquire or redeem entity's shares |
0.00 |
|
Payments of other equity instruments |
0.00 |
|
Proceeds from exercise of stock options |
0.00 |
|
Proceeds from issuing debentures notes bonds etc |
0.00 |
|
Proceeds from borrowings |
24,090.00 |
|
Repayments of borrowings |
12,130.00 |
|
Payments of lease liabilities |
15,300.00 |
|
Dividends paid |
15,040.00 |
|
Interest paid |
11,750.00 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
(840.00) |
|
Net cash flows from (used in)
financing activities |
(30,340.00) |
|
Net increase (decrease) in cash
and cash equivalents before effect of exchange rate changes |
(22,390.00) |
|
Effect of exchange rate changes
on cash and cash equivalents |
|
|
Effect of exchange rate changes on cash and cash equivalents |
0.00 |
|
Net increase (decrease) in cash
and cash equivalents |
(22,390.00) |
|
Cash and cash equivalents cash flow statement at beginning of period
|
81,130.00 |
|
Cash and cash equivalents cash
flow statement at end of period |
58,740.00 |
Details of Impact of Audit Qualification
Amount in (Lakhs)
| Whether results are audited or unaudited |
Unaudited |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
| Auditor's opinion |
|
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015:
The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified
opinion for the period on Standalone results |
Yes |
| Sr No. |
Audit firm's name |
Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI |
Certificate valid upto |
| 1 |
DELOITTE HASKINS & SELLS LLP |
Yes |
31-07-2027 |